NASDAQ:GTXI - GTX Stock Price, Price Target & More

$16.95 -0.29 (-1.68 %)
(As of 04/25/2018 10:36 AM ET)
Previous Close$17.24
Today's Range$16.88 - $17.71
52-Week Range$2.73 - $23.40
Volume6,609 shs
Average Volume101,654 shs
Market Capitalization$380.06 million
P/E Ratio-9.85
Dividend YieldN/A
Beta1.61

About GTX (NASDAQ:GTXI)

GTX logoGTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of medicines for the treatment of stress urinary incontinence (SUI) and prostate cancer. It focuses on the development of selective androgen receptor modulators (SARMs) for the treatment of breast cancer, SUI, and Duchenne muscular dystrophy; and selective androgen receptor degraders to treat progressive castration-resistant prostate cancer. The company's lead SARM candidate is the enobosarm GTx-024, a Phase II open-label proof-of-concept clinical trial for patients with androgen receptor (AR) positive triple-negative breast cancer; and estrogen receptor positive and AR positive advanced breast cancer, as well as postmenopausal women with SUI. GTx, Inc. was founded in 1997 and is headquartered in Memphis, Tennessee.

Receive GTXI News and Ratings via Email

Sign-up to receive the latest news and ratings for GTXI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryBiotechnology
SectorMedical
SymbolNASDAQ:GTXI
CUSIP40052B10
Phone901-523-9700

Debt

Debt-to-Equity RatioN/A
Current Ratio5.78%
Quick Ratio5.78%

Price-To-Earnings

Trailing P/E Ratio-9.85
Forward P/E Ratio-9.52
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$1.78 per share
Price / Book9.52

Profitability

EPS (Most Recent Fiscal Year)($1.75)
Net Income$-30,430,000.00
Net MarginsN/A
Return on Equity-113.27%
Return on Assets-90.41%

Miscellaneous

Employees27
Outstanding Shares21,850,000

How to Become a New Pot Stock Millionaire

GTX (NASDAQ:GTXI) Frequently Asked Questions

What is GTX's stock symbol?

GTX trades on the NASDAQ under the ticker symbol "GTXI."

How were GTX's earnings last quarter?

GTx Incorporated (NASDAQ:GTXI) announced its quarterly earnings results on Monday, March, 12th. The biopharmaceutical company reported ($0.43) EPS for the quarter, beating the consensus estimate of ($0.48) by $0.05. View GTX's Earnings History.

When is GTX's next earnings date?

GTX is scheduled to release their next quarterly earnings announcement on Wednesday, May, 9th 2018. View Earnings Estimates for GTX.

What price target have analysts set for GTXI?

2 brokers have issued twelve-month price targets for GTX's stock. Their predictions range from $30.00 to $45.00. On average, they expect GTX's stock price to reach $37.50 in the next year. View Analyst Ratings for GTX.

Who are some of GTX's key competitors?

Who are GTX's key executives?

GTX's management team includes the folowing people:
  • Dr. Robert James Wills, Exec. Chairman (Age 64)
  • Mr. Marc S. Hanover, Co-Founder, CEO & Director (Age 55)
  • Mr. Henry P. Doggrell, VP, Chief Legal Officer, Gen. Counsel & Sec. (Age 69)
  • Mr. Jason T. Shackelford, VP of Fin. & Accounting, Principal Financial & Accounting Officer and Corp. Controller (Age 43)
  • Dr. Diane C. Young M.D., Chief Medical Officer and VP (Age 61)

Has GTX been receiving favorable news coverage?

News headlines about GTXI stock have trended somewhat positive recently, Accern reports. The research firm scores the sentiment of news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. GTX earned a media sentiment score of 0.10 on Accern's scale. They also assigned media headlines about the biopharmaceutical company an impact score of 44.95 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

How do I buy shares of GTX?

Shares of GTXI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is GTX's stock price today?

One share of GTXI stock can currently be purchased for approximately $16.95.

How big of a company is GTX?

GTX has a market capitalization of $380.06 million. The biopharmaceutical company earns $-30,430,000.00 in net income (profit) each year or ($1.75) on an earnings per share basis. GTX employs 27 workers across the globe.

How can I contact GTX?

GTX's mailing address is 175 TOYOTA PLAZA 7TH FLOOR, MEMPHIS TN, 38103. The biopharmaceutical company can be reached via phone at 901-523-9700 or via email at [email protected]


MarketBeat Community Rating for GTX (GTXI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  134 (Vote Outperform)
Underperform Votes:  137 (Vote Underperform)
Total Votes:  271
MarketBeat's community ratings are surveys of what our community members think about GTX and other stocks. Vote "Outperform" if you believe GTXI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GTXI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

GTX (NASDAQ:GTXI) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for GTX in the last 12 months. Their average twelve-month price target is $37.50, suggesting that the stock has a possible upside of 121.24%. The high price target for GTXI is $45.00 and the low price target for GTXI is $30.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $37.50$37.50$17.00N/A
Price Target Upside: 121.24% upside79.60% upside52.88% upsideN/A

GTX (NASDAQ:GTXI) Consensus Price Target History

Price Target History for GTX (NASDAQ:GTXI)

GTX (NASDAQ:GTXI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/15/2018Robert W. BairdReiterated RatingBuy$30.00LowView Rating Details
3/5/2018Stifel NicolausBoost Price TargetBuy -> Buy$16.00 -> $45.00HighView Rating Details
9/9/2016Jefferies GroupReiterated RatingHold$1.00N/AView Rating Details
(Data available from 4/25/2016 forward)

Earnings

GTX (NASDAQ:GTXI) Earnings History and Estimates Chart

Earnings by Quarter for GTX (NASDAQ:GTXI)

GTX (NASDAQ:GTXI) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.78 EPS
Next Year EPS Consensus Estimate: $-1.66 EPS

GTX (NASDAQ GTXI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2018($0.43)N/AView Earnings Details
3/12/2018Q4 2017($0.48)($0.43)ViewN/AView Earnings Details
11/14/2017Q3 2017($0.28)($0.53)ViewN/AView Earnings Details
8/14/2017Q2 2017($0.40)ViewN/AView Earnings Details
5/15/2017Q1 2017($0.39)ViewN/AView Earnings Details
3/15/2017Q4 2016($0.57)($0.44)ViewN/AView Earnings Details
11/3/2016Q3($0.05)($0.05)ViewN/AView Earnings Details
8/9/2016Q2($0.05)($0.04)ViewN/AView Earnings Details
5/10/2016Q1($0.04)$0.01ViewN/AView Earnings Details
3/3/2016Q415($0.10)($0.04)ViewListenView Earnings Details
10/29/2015Q315($0.06)($0.04)ViewListenView Earnings Details
8/6/2015Q215($0.04)($0.03)ViewListenView Earnings Details
5/8/2015Q1($0.04)($0.04)ViewListenView Earnings Details
3/4/2015Q314($0.07)($0.05)ViewListenView Earnings Details
11/10/2014Q214($0.10)($0.06)ViewListenView Earnings Details
8/5/2014Q2($0.11)($0.15)ViewN/AView Earnings Details
5/8/2014Q114($0.12)($0.14)ViewN/AView Earnings Details
3/4/2014Q413($0.13)($0.12)ViewListenView Earnings Details
11/12/2013Q313($0.21)($0.14)ViewListenView Earnings Details
7/19/2013Q2 2013($0.22)($0.20)ViewN/AView Earnings Details
5/3/2013Q1 2013($0.21)($0.20)ViewListenView Earnings Details
2/21/2013Q4 2012($0.21)($0.17)ViewListenView Earnings Details
11/8/2012Q312($0.17)$0.12$1.93 millionViewN/AView Earnings Details
8/8/2012($0.17)($0.17)ViewN/AView Earnings Details
5/8/2012($0.17)($0.18)ViewN/AView Earnings Details
2/21/2012($0.17)($0.17)ViewN/AView Earnings Details
11/4/2011($0.18)($0.15)ViewN/AView Earnings Details
8/9/2011($0.19)($0.21)ViewN/AView Earnings Details
5/9/2011($0.13)($0.05)ViewN/AView Earnings Details
2/24/2011($0.16)($0.16)ViewN/AView Earnings Details
11/9/2010Q3 2010($2.90)($2.35)ViewN/AView Earnings Details
8/9/2010Q2 2010($2.70)($3.55)ViewN/AView Earnings Details
5/4/2010Q1 2010$11.60$12.17ViewN/AView Earnings Details
3/15/2010Q4 2009($3.50)($3.00)ViewN/AView Earnings Details
11/9/2009Q3 2009($3.40)($3.52)ViewN/AView Earnings Details
8/10/2009Q2 2009($3.60)($3.09)ViewN/AView Earnings Details
5/11/2009Q1 2009($3.80)($3.10)ViewN/AView Earnings Details
2/17/2009Q4 2008($3.90)($3.81)ViewN/AView Earnings Details
11/6/2008Q3 2008($4.30)($3.28)ViewN/AView Earnings Details
8/5/2008Q2 2008($3.80)($3.66)ViewN/AView Earnings Details
5/12/2008Q1 2008($3.10)($3.52)ViewN/AView Earnings Details
2/19/2008Q4 2007($3.40)($3.64)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

GTX (NASDAQ:GTXI) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

GTX (NASDAQ GTXI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 40.90%
Institutional Ownership Percentage: 12.71%
Insider Trading History for GTX (NASDAQ:GTXI)
Insider Trading History for GTX (NASDAQ:GTXI)

GTX (NASDAQ GTXI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/5/2018Henry Patton DoggrellVPSell4,965$11.33$56,253.4554,804View SEC Filing  
1/5/2018Jason T ShackelfordInsiderSell3,090$11.33$35,009.7031,111View SEC Filing  
1/5/2018Marc Steven HanoverCEOSell7,309$11.33$82,810.97129,990View SEC Filing  
10/14/2016Peak Foundation PyramidMajor ShareholderBuy7,716,049$0.81$6,249,999.6938,249,528View SEC Filing  
6/16/2016Robert James WillsChairmanBuy100,000$0.65$65,000.001,200,000View SEC Filing  
3/1/2016J Kenneth GlassDirectorBuy44,000$0.60$26,400.00183,768View SEC Filing  
1/26/2016Marc Steven HanoverCEOBuy4,000$0.65$2,600.001,257,224View SEC Filing  
1/25/2016Marc Steven HanoverCEOBuy12,813$0.63$8,072.191,253,224View SEC Filing  
1/19/2016Marc Steven HanoverCEOBuy25,000$0.50$12,500.001,240,411View SEC Filing  
1/14/2016Marc Steven HanoverCEOBuy25,000$0.49$12,250.001,193,311View SEC Filing  
12/24/2015J Kenneth GlassDirectorBuy100$0.79$79.00139,768View SEC Filing  
12/22/2015J Kenneth GlassDirectorBuy1,907$0.78$1,487.46139,068View SEC Filing  
12/21/2015J Kenneth GlassDirectorBuy39,900$0.78$31,122.00137,761View SEC Filing  
5/19/2015J Kenneth GlassDirectorBuy24,500$1.25$30,625.00View SEC Filing  
5/14/2015Robert James WillsChairmanBuy46,140$0.96$44,294.40View SEC Filing  
5/8/2015Henry Patton DoggrellVPBuy25,477$0.80$20,381.60View SEC Filing  
5/8/2015Robert James WillsChairmanBuy50,000$0.80$40,000.00View SEC Filing  
4/22/2015J Kenneth GlassDirectorBuy10,000$0.72$7,200.00View SEC Filing  
4/21/2015J Kenneth GlassDirectorBuy11,608$0.71$8,241.68View SEC Filing  
4/15/2015J Kenneth GlassDirectorBuy3,300$0.72$2,376.00View SEC Filing  
4/10/2015J Kenneth GlassDirectorBuy16,400$0.67$10,988.00View SEC Filing  
9/23/2014Marc Steven HanoverCEOBuy5,000$0.75$3,750.00View SEC Filing  
9/17/2014Marc Steven HanoverCEOBuy10,000$0.74$7,400.00View SEC Filing  
8/21/2014Marc Steven HanoverCEOBuy20,000$1.00$20,000.00View SEC Filing  
8/19/2014Marc Steven HanoverCEOBuy10,000$1.01$10,100.00View SEC Filing  
8/8/2014Henry Patton DoggrellVPBuy10,000$0.97$9,700.00View SEC Filing  
8/8/2014Marc Steven HanoverCEOBuy30,000$0.93$27,900.00View SEC Filing  
8/7/2014Jason T ShackelfordInsiderBuy10,000$0.92$9,200.00View SEC Filing  
8/7/2014Marc Steven HanoverCEOBuy30,000$0.92$27,600.00View SEC Filing  
6/6/2014James T DaltonVPSell72,883$1.30$94,747.90View SEC Filing  
3/21/2014Jack Schulermajor shareholderSell1,192,251$1.84$2,193,741.846,165,261View SEC Filing  
8/22/2013Jack Schulermajor shareholderBuy93,777$1.36$127,536.727,357,512View SEC Filing  
8/21/2013Jack Schulermajor shareholderBuy309,591$1.42$439,619.227,263,735View SEC Filing  
7/9/2013Mark Edward MostellerCFOSell17,000$6.99$118,830.00View SEC Filing  
1/17/2013James T DaltonVPSell20,000$5.20$104,000.00View SEC Filing  
12/14/2012Timothy R G SearDirectorBuy50,000$4.33$216,500.00View SEC Filing  
8/27/2012J Kenneth GlassDirectorBuy10,000$3.76$37,600.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

GTX (NASDAQ GTXI) News Headlines

Source:
DateHeadline
GTX (GTXI) Lowered to Hold at BidaskClubGTX (GTXI) Lowered to Hold at BidaskClub
www.americanbankingnews.com - April 17 at 9:57 AM
BRIEF-Gtx To Present Phase 2 Enobosarm Clinical Trial Results In Stress Urinary IncontinenceBRIEF-Gtx To Present Phase 2 Enobosarm Clinical Trial Results In Stress Urinary Incontinence
www.reuters.com - April 17 at 9:30 AM
Zacks: Analysts Set $37.50 Price Target for GTx Incorporated (GTXI)Zacks: Analysts Set $37.50 Price Target for GTx Incorporated (GTXI)
www.americanbankingnews.com - April 16 at 7:25 PM
GTx to Present Phase 2 Enobosarm Clinical Trial Results in Stress Urinary Incontinence at a Podium Presentation at 2018 AUA Annual MeetingGTx to Present Phase 2 Enobosarm Clinical Trial Results in Stress Urinary Incontinence at a Podium Presentation at 2018 AUA Annual Meeting
finance.yahoo.com - April 16 at 9:03 AM
Ra Pharmaceuticals (RARX) vs. GTX (GTXI) Head-To-Head ComparisonRa Pharmaceuticals (RARX) vs. GTX (GTXI) Head-To-Head Comparison
www.americanbankingnews.com - April 14 at 9:33 AM
Research Report Identifies Third Point Reinsurance, GTx, pdvWireless, ACM Research, Reading International, and Canadian National Railway with Renewed Outlook — Fundamental Analysis, Calculating Forward MovementResearch Report Identifies Third Point Reinsurance, GTx, pdvWireless, ACM Research, Reading International, and Canadian National Railway with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
finance.yahoo.com - April 13 at 9:25 AM
 Brokerages Expect GTx Incorporated (GTXI) to Announce -$0.43 Earnings Per Share Brokerages Expect GTx Incorporated (GTXI) to Announce -$0.43 Earnings Per Share
www.americanbankingnews.com - April 11 at 11:16 PM
Active-Investors: Blog Exposure - GTx Completed Patient Enrollment Several Months Ahead in the Phase-2 Clinical Trial of Enobosarm in SUIActive-Investors: Blog Exposure - GTx Completed Patient Enrollment Several Months Ahead in the Phase-2 Clinical Trial of Enobosarm in SUI
www.finanznachrichten.de - April 11 at 9:44 AM
The Medical Report: Saint Francis promotes new COO; GTx study aims to fix leaksThe Medical Report: Saint Francis promotes new COO; GTx study aims to fix leaks
www.bizjournals.com - April 9 at 4:40 PM
GTx completes patient enrollment in a Phase 2 clinical trial of enobosarm in SUIGTx completes patient enrollment in a Phase 2 clinical trial of enobosarm in SUI
seekingalpha.com - April 9 at 9:21 AM
GTx Announces Early Completion of Patient Enrollment in the ASTRID Trial, a Phase 2 Clinical Trial of Enobosarm in Stress Urinary IncontinenceGTx Announces Early Completion of Patient Enrollment in the ASTRID Trial, a Phase 2 Clinical Trial of Enobosarm in Stress Urinary Incontinence
finance.yahoo.com - April 9 at 9:21 AM
GTX (GTXI) Rating Increased to Buy at ValuEngineGTX (GTXI) Rating Increased to Buy at ValuEngine
www.americanbankingnews.com - April 3 at 3:00 PM
GTX (GTXI) Now Covered by Stifel NicolausGTX (GTXI) Now Covered by Stifel Nicolaus
www.americanbankingnews.com - March 31 at 8:16 PM
GTX (GTXI) Downgraded to "Sell" at Zacks Investment ResearchGTX (GTXI) Downgraded to "Sell" at Zacks Investment Research
www.americanbankingnews.com - March 29 at 8:30 PM
Xiaomi’s Mi Gaming Laptop comes with Nvidia GTX 1060 graphics and costs $1,430Xiaomi’s Mi Gaming Laptop comes with Nvidia GTX 1060 graphics and costs $1,430
www.msn.com - March 29 at 9:28 AM
GTX (GTXI) Lifted to Hold at Zacks Investment ResearchGTX (GTXI) Lifted to Hold at Zacks Investment Research
www.americanbankingnews.com - March 27 at 10:56 PM
Xiaomi unveils a gaming laptop with Kaby Lake CPU, NVIDIA GTX 1060, and RGB lightingXiaomi unveils a gaming laptop with Kaby Lake CPU, NVIDIA GTX 1060, and RGB lighting
www.msn.com - March 27 at 9:33 AM
Zacks: Analysts Expect GTx Incorporated (GTXI) to Post -$0.43 EPSZacks: Analysts Expect GTx Incorporated (GTXI) to Post -$0.43 EPS
www.americanbankingnews.com - March 25 at 11:12 PM
GTX (GTXI) Stock Rating Upgraded by ValuEngineGTX (GTXI) Stock Rating Upgraded by ValuEngine
www.americanbankingnews.com - March 25 at 11:22 AM
GTX (GTXI) Given "Buy" Rating at Robert W. BairdGTX (GTXI) Given "Buy" Rating at Robert W. Baird
www.americanbankingnews.com - March 24 at 12:10 PM
GTX (GTXI) Lowered to Buy at BidaskClubGTX (GTXI) Lowered to Buy at BidaskClub
www.americanbankingnews.com - March 22 at 12:56 AM
 Analysts Set $37.50 Price Target for GTx, Inc. (GTXI) Analysts Set $37.50 Price Target for GTx, Inc. (GTXI)
www.americanbankingnews.com - March 17 at 1:43 PM
GTXs (GTXI) "Buy" Rating Reiterated at Robert W. BairdGTX's (GTXI) "Buy" Rating Reiterated at Robert W. Baird
www.americanbankingnews.com - March 15 at 3:02 PM
Report: Developing Opportunities within Odonate Therapeutics, Greenlight Reinsurance, Landmark Infrastructure Partners LP, GTx, First Mid-Illinois Bancshares, and iClick Interactive Asia Group — Future Expectations, Projections Moving into 2018Report: Developing Opportunities within Odonate Therapeutics, Greenlight Reinsurance, Landmark Infrastructure Partners LP, GTx, First Mid-Illinois Bancshares, and iClick Interactive Asia Group — Future Expectations, Projections Moving into 2018
finance.yahoo.com - March 15 at 9:02 AM
GTX (GTXI) Announces Quarterly  Earnings ResultsGTX (GTXI) Announces Quarterly Earnings Results
www.americanbankingnews.com - March 13 at 10:39 AM
GTx reports 4Q lossGTx reports 4Q loss
finance.yahoo.com - March 12 at 5:47 PM
GTx Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial ResultsGTx Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - March 12 at 5:47 PM
Zacks: GTx, Inc. (GTXI) Given Consensus Rating of "Strong Buy" by AnalystsZacks: GTx, Inc. (GTXI) Given Consensus Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - March 7 at 3:28 PM
GTX (GTXI) to Release Earnings on TuesdayGTX (GTXI) to Release Earnings on Tuesday
www.americanbankingnews.com - March 6 at 2:32 AM
GTx, Inc. (GTXI) Soars 25% in Light of Encouraging Data in SUIGTx, Inc. (GTXI) Soars 25% in Light of Encouraging Data in SUI
finance.yahoo.com - March 5 at 5:15 PM
Why Square, CF Industries Holdings, and GTx Jumped TodayWhy Square, CF Industries Holdings, and GTx Jumped Today
finance.yahoo.com - March 5 at 5:15 PM
GTx shares surge 30% on incontinence trial resultsGTx shares surge 30% on incontinence trial results
finance.yahoo.com - March 5 at 5:15 PM
GTX (GTXI) PT Raised to $45.00 at Stifel NicolausGTX (GTXI) PT Raised to $45.00 at Stifel Nicolaus
www.americanbankingnews.com - March 5 at 1:58 PM
GTx Announced New Data Demonstrating Enobosarm’s Potential to Treat Stress Urinary Incontinence at SUFU 2018GTx Announced New Data Demonstrating Enobosarm’s Potential to Treat Stress Urinary Incontinence at SUFU 2018
finance.yahoo.com - March 5 at 9:16 AM
GTX (GTXI) Lifted to Strong-Buy at BidaskClubGTX (GTXI) Lifted to Strong-Buy at BidaskClub
www.americanbankingnews.com - February 25 at 5:28 PM
Reviewing Corvus Pharmaceuticals (CRVS) & GTX (GTXI)Reviewing Corvus Pharmaceuticals (CRVS) & GTX (GTXI)
www.americanbankingnews.com - February 22 at 11:12 PM
GTx Phase 2 Enobosarm Clinical Trial Results in Stress Urinary Incontinence Accepted for Podium Presentation at SUFUGTx Phase 2 Enobosarm Clinical Trial Results in Stress Urinary Incontinence Accepted for Podium Presentation at SUFU
finance.yahoo.com - February 22 at 5:02 PM
Zacks: GTx, Inc. (GTXI) Receives Average Recommendation of "Strong Buy" from AnalystsZacks: GTx, Inc. (GTXI) Receives Average Recommendation of "Strong Buy" from Analysts
www.americanbankingnews.com - February 20 at 5:32 PM
BidaskClub Lowers GTX (GTXI) to BuyBidaskClub Lowers GTX (GTXI) to Buy
www.americanbankingnews.com - February 18 at 2:40 PM
Zacks: Analysts Set $16.50 Price Target for GTx, Inc. (GTXI)Zacks: Analysts Set $16.50 Price Target for GTx, Inc. (GTXI)
www.americanbankingnews.com - February 8 at 7:20 PM
Contrasting SAGE Therapeutics (SAGE) and GTX (GTXI)Contrasting SAGE Therapeutics (SAGE) and GTX (GTXI)
www.americanbankingnews.com - January 30 at 3:20 PM
BidaskClub Upgrades GTX (GTXI) to Strong-BuyBidaskClub Upgrades GTX (GTXI) to Strong-Buy
www.americanbankingnews.com - January 27 at 3:24 PM
Zacks: Brokerages Anticipate GTx, Inc. (GTXI) Will Post Earnings of -$0.39 Per ShareZacks: Brokerages Anticipate GTx, Inc. (GTXI) Will Post Earnings of -$0.39 Per Share
www.americanbankingnews.com - January 17 at 3:12 AM
Jason T. Shackelford Sells 3,090 Shares of GTx, Inc. (GTXI) StockJason T. Shackelford Sells 3,090 Shares of GTx, Inc. (GTXI) Stock
www.americanbankingnews.com - January 9 at 7:56 PM
GTx, Inc. (GTXI) VP Sells $56,253.45 in StockGTx, Inc. (GTXI) VP Sells $56,253.45 in Stock
www.americanbankingnews.com - January 9 at 7:16 PM
GTx, Inc. (GTXI) CEO Sells $82,810.97 in StockGTx, Inc. (GTXI) CEO Sells $82,810.97 in Stock
www.americanbankingnews.com - January 9 at 7:16 PM
Analysts Expect GTx, Inc. (GTXI) to Post ($0.39) EPSAnalysts Expect GTx, Inc. (GTXI) to Post ($0.39) EPS
www.americanbankingnews.com - January 8 at 9:40 AM
BRIEF-GTX Inc Files For Mixed Shelf Offering Of Up To $150 MlnBRIEF-GTX Inc Files For Mixed Shelf Offering Of Up To $150 Mln
www.reuters.com - December 23 at 9:19 PM
 GTx, Inc. (GTXI) Receives Consensus Rating of "Strong Buy" from Brokerages GTx, Inc. (GTXI) Receives Consensus Rating of "Strong Buy" from Brokerages
www.americanbankingnews.com - December 23 at 11:40 AM
-$0.39 Earnings Per Share Expected for GTx, Inc. (GTXI) This Quarter-$0.39 Earnings Per Share Expected for GTx, Inc. (GTXI) This Quarter
www.americanbankingnews.com - December 14 at 7:16 AM

SEC Filings

GTX (NASDAQ:GTXI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

GTX (NASDAQ:GTXI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

GTX (NASDAQ GTXI) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.